肝细胞癌与肝内胆管癌治疗反应中肿瘤细胞演变的单细胞图谱
研究对37例患者的46份肝细胞癌和肝内胆管癌活检组织进行单细胞转录组分析,其中7例有16份治疗前后配对样本;发现肿瘤细胞状态异质性增加与患者预后紧密相关,SPP1表达与肿瘤细胞演变及微环境重编程密切相关。
要点
- 肿瘤细胞功能克隆性增加伴随免疫细胞 landscape 极化,包括前耗竭T细胞增多。
- SPP1表达与肿瘤细胞演变和微环境重编程紧密相关。
- 肿瘤细胞状态异质性增加与患者预后紧密相关。
核心结论
- 肝细胞癌和肝内胆管癌治疗反应中肿瘤细胞状态异质性增加,且与患者预后紧密相关。
- SPP1表达与肿瘤细胞演变及微环境重编程紧密相关,可能作为治疗反应的候选调控因子。
研究设计与样本
- 分析37例患者的46份肝细胞癌和肝内胆管癌活检组织,其中7例患者有16份治疗前后配对样本。
- 采用基于机器学习的共识聚类方法追踪57,000个恶性和非恶性细胞的细胞状态。
- 利用RNA velocity和反向图嵌入确定肿瘤细胞关系,并在4例患者的纵向样本中研究肿瘤细胞状态及演变。
- 在488例肝细胞癌和277例肝内胆管癌患者的bulk转录组数据中验证发现。
主要发现
- 以转录组聚类作为功能克隆性的替代指标,观察到肿瘤细胞状态异质性增加,且与患者预后紧密相关。
- 功能克隆性增加伴随免疫细胞 landscape 极化,包括前耗竭T细胞增多。
- SPP1表达与肿瘤细胞演变和微环境重编程紧密相关。
临床怎么用
- SPP1可能作为肝细胞癌和肝内胆管癌治疗反应中肿瘤演变的候选调控因子。
- 肿瘤细胞状态异质性可作为患者预后的潜在参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Intratumor molecular heterogeneity is a key feature of tumorigenesis and is linked to treatment failure and patient prognosis. Herein, we aimed to determine what drives tumor cell evolution by performing single-cell transcriptomic analysis. METHODS: We analyzed 46 hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) biopsies from 37 patients enrolled in interventional studies at the NIH Clinical Center, with 16 biopsies collected before and after treatment from 7 patients. We developed a novel machine learning-based consensus clustering approach to track cellular states of 57,000 malignant and non-malignant cells including tumor cell transcriptome-based functional clonality analysis. We determined tumor cell relationships using RNA velocity and reverse graph embedding. We also studied longitudinal samples from 4 patients to determine tumor cellular state and its evolution. We validated our findings in bulk transcriptomic data from 488 patients with HCC and 277 patients with iCCA. RESULTS: Using transcriptomic clusters as a surrogate for functional clonality, we observed an increase in tumor cell state heterogeneity which was tightly linked to patient prognosis. Furthermore, increased functional clonality was accompanied by a polarized immune cell landscape which included an increase in pre-exhausted T cells. We found that SPP1 expression was tightly associated with tumor cell evolution and microenvironmental reprogramming. Finally, we developed a user-friendly online interface as a knowledge base for a single-cell atlas of liver cancer. CONCLUSIONS: Our study offers insight into the collective behavior of tumor cell communities in liver cancer as well as potential drivers of tumor evolution in response to therapy. LAY SUMMARY: Intratumor molecular heterogeneity is a key feature of tumorigenesis that is linked to treatment failure and patient prognosis. In this study, we present a single-cell atlas of liver tumors from patients treated with immunotherapy and describe intratumoral cell states and their hierarchical relationship. We suggest osteopontin, encoded by the gene SPP1, as a candidate regulator of tumor evolution in response to treatment.
引用
- Ma L, Wang L, Khatib SA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021. PMID: 34216724. doi:10.1016/j.jhep.2021.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。